Late presentation of chronic myeloid leukaemia patients in a low-income country: the prognostic implications and impact on treatment outcome
EA Nelson, IO Ahmed, RA Bolarinwa, BA Adeagbo… - BMC Research …, 2024 - Springer
Abstract Background In Nigeria, since 2002, Imatinib mesylate (glivec®) has been available
freely to chronic myeloid leukaemia (CML) patients but only at a tertiary health care centre in …
freely to chronic myeloid leukaemia (CML) patients but only at a tertiary health care centre in …